Barclays Issues Positive Forecast for DaVita (NYSE:DVA) Stock Price

DaVita (NYSE:DVA) had its price objective boosted by Barclays from $164.00 to $169.00 in a research note released on Tuesday,Benzinga reports. The brokerage currently has an equal weight rating on the stock.

DaVita Trading Down 1.6 %

NYSE DVA opened at $154.98 on Tuesday. The firm has a market capitalization of $12.71 billion, a P/E ratio of 16.72, a PEG ratio of 0.84 and a beta of 0.94. The business has a fifty day simple moving average of $161.41 and a 200 day simple moving average of $157.91. DaVita has a 12 month low of $119.42 and a 12 month high of $179.60. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78.

DaVita (NYSE:DVA) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 88.18% and a net margin of 6.53%. On average, analysts predict that DaVita will post 9.71 EPS for the current fiscal year.

Institutional Investors Weigh In On DaVita

Large investors have recently made changes to their positions in the business. Franklin Resources Inc. increased its position in shares of DaVita by 134.6% during the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock valued at $8,885,000 after purchasing an additional 31,502 shares during the last quarter. FMR LLC increased its position in shares of DaVita by 659.9% during the 3rd quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after purchasing an additional 154,061 shares during the last quarter. Atom Investors LP purchased a new stake in shares of DaVita during the 3rd quarter valued at $4,094,000. Assenagon Asset Management S.A. increased its position in shares of DaVita by 201.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock valued at $11,159,000 after purchasing an additional 49,885 shares during the last quarter. Finally, Neo Ivy Capital Management purchased a new stake in shares of DaVita during the 3rd quarter valued at $726,000. 90.12% of the stock is owned by hedge funds and other institutional investors.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.